The Neothink Society · Health and Vitality · August 2009
Cancer took a generation of lives to the only treatment available, the surgeon's blade, because medicine had nothing more precise to offer. A father who endured five surgeries between 1958 and the end did not die of the disease alone; he died of the gap between what was possible and what had been built. The Neothink mind reads the case below as evidence of how fast value can reach the sick once the obstacles between discovery and patient are cleared.
Albina Duggan was diagnosed with Stage IV cancer. A mother of four, she was told she had three to five years left. The disease had spread from her liver to her spine and lymph nodes. Five years later, at 41, her tumors had shrunk by half and her doctors had stopped putting a number on her life. Her treatment combined a glass of grapefruit juice with a cancer drug then in clinical trials: rapamycin.
A University of Chicago clinical trial found that a chemical in grapefruit juice raised the effectiveness of rapamycin. A daily glass of freshly frozen juice paired with a weekly dose of the drug helped halt tumor growth, according to the study's lead. The mechanism is direct. Rapamycin stops cells from multiplying, which keeps cancer growth in check, but an enzyme in the intestine breaks the drug down so that only a fraction of what a patient swallows reaches the bloodstream. Grapefruit juice contains compounds called furanocoumarins that block that enzyme. With the enzyme suppressed, far more of the drug is absorbed.
The Mechanism A short-lived compound in fresh grapefruit juice blocks the intestinal enzyme that destroys rapamycin, so far more of the drug reaches the bloodstream and the dose can do its work.
That same property is why patients are routinely warned never to wash pills down with grapefruit juice: it amplifies the potency of many drugs in the body. Here the amplification was the point, harnessed deliberately by clinicians who understood the biochemistry.
The quality of the juice decided the result. Store-bought grapefruit juice is not the grade used in the trial. A citrus monitoring and regulatory department in Florida saw a report on Dr. Cohen's work, contacted him, and explained that the key chemicals in grapefruit juice have a short shelf life and degrade during processing and sale. They sent him a more potent, freshly frozen form. That juice raised drug levels in the blood of the patients in the study, and it led Cohen to ask whether the same grade of juice could boost other cancer-fighting drugs.
Cohen described the enzyme grapefruit juice blocks as one that "normally protects us from other toxic chemicals and metabolizes them to harmless byproducts." Albina Duggan put her own prognosis plainly. Her life expectancy, she said, is "indefinite." "There is nothing in my charts that will point to any number. I might outlive everybody."
The grapefruit-juice and rapamycin case proves the cure for many patients already exists; what stands between the discovery and the sick is the friction the Neothink mind works to remove.
As one writer noted, grapefruit contains a substance called naringin that changes how the liver and the body's detoxification system process certain drugs. Clinicians who know what they are doing can use that interaction; the public should not attempt it while taking medication without consulting a medical professional first, since many prescription drugs carry warnings against grapefruit juice for exactly this reason. A whole-foods diet built on fruits and vegetables remains sound counsel. The interaction itself is pure pharmacology.
The Friction Value existed and the path to deliver it existed; what slowed the cure was the structure standing between discovery and patient.
The harder lesson sits underneath the chemistry. The citrus manufacturers sell the weaker juice, in part to avoid liability. The potent grade that helped patients was the one held back by the structure around it. Value existed, the path to deliver it existed, and the friction between discovery and patient slowed it. More people reach a cure when that friction is removed. The Neothink mind works to remove that friction so the cure reaches the patient.
Common Questions
What did the grapefruit juice and rapamycin finding actually show? A University of Chicago clinical trial found that a daily glass of a potent, freshly frozen grapefruit juice paired with a weekly dose of rapamycin helped halt tumor growth. In one documented Stage IV case, Albina Duggan's tumors shrank by half and her doctors stopped putting a number on her life expectancy. The juice raised the drug's effectiveness rather than fighting cancer on its own.
What is the mechanism that makes the juice raise the drug's effect? Rapamycin stops cells from multiplying, which keeps cancer growth in check, but an enzyme in the intestine breaks the drug down so only a fraction of a swallowed dose reaches the bloodstream. Grapefruit juice contains compounds called furanocoumarins that block that enzyme. With the enzyme suppressed, far more of the drug is absorbed and the dose can do its work.
Why does store-bought grapefruit juice not reproduce the result? The key chemicals have a short shelf life and degrade during processing and sale, so the juice on the shelf is a weaker grade than the one used in the trial. A Florida citrus monitoring department supplied the researchers with a more potent, freshly frozen form, and that grade was what raised drug levels in the patients' blood.
Why are patients warned not to take grapefruit juice with their medication? The same enzyme-blocking property that helped here amplifies the potency of many drugs in the body, which can be dangerous. Many prescription drugs carry explicit warnings against grapefruit juice for exactly this reason. In the trial the amplification was harnessed deliberately by clinicians who understood the biochemistry; it is not something to attempt without a medical professional.
What held the potent grade of juice back? The citrus manufacturers sell the weaker juice in part to avoid liability. The more potent grade that helped patients was the one the surrounding structure held back, so a usable value existed while the friction between discovery and patient slowed its delivery.
What does the Neothink mind read in this case? It reads evidence of how fast value can reach the sick once the obstacles between discovery and patient are cleared. The same trial data was available to everyone; the Neothink mind sees in it a working cure already in hand and a structure of friction worth removing so the cure reaches the patient.
Further Reading
- The Neothink Mind. The way of thinking that reads the same evidence everyone saw and finds the value others miss.
- Value Creation. Why a real cure reaches more people only when the friction between discovery and patient is removed.
- Neovia. The discovery-to-deployment cure zone built to move treatments from the lab to the sick without delay.
- Integrated Thinking. The mode in which separate facts, here chemistry, regulation, and liability, lock into one working picture.
- Health and Vitality. How members of the Neothink Society apply this thinking across health and the body.
Disclaimer: The information presented here is not intended to treat or diagnose any medical condition. As always, discuss your options with your medical doctor.
Membership is by application.